0000000000872965

AUTHOR

P. Dorangricchia

showing 2 related works from this author

Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis

2016

The purpose of this statistical analysis is to demonstrate the real advantages in terms of cost-benefit of combination chemotherapy compared with single-agent chemotherapy. The trials, which are used in this meta-analysis, have been searched on PubMed database and they are phase II or randomized phase III studies with only chemotherapy regimens. In this meta-analysis were evaluated adverse effects with odds ratio (OR), which is expressed in 95% confidence intervals (95% CI). Only 4 studies contained all the set selection criteria and they were selected. The data, which were obtained, were analyzed using MedCalc Application. The combination therapy was more strongly linked to certain adverse…

Combination chemotherapySingle-agent chemotherapyToxicityOvarian cancerMedicine (all)Meta-analysi
researchProduct

The patient-physician relationship in the face of oncological disease: A review of literature on the emotional and psychological reactions of patient…

2016

The physician-patient relationship is daily destabilized by emotional reactions and psychic defenses that cancer arises in the two partners. Continued scientific and technological progresses which were reached by medicine in recent years, and particularly oncologic clinical discoveries, increased the chance of not only survival but also healing. Nevertheless, cancer diagnosis is still a hard existential text that destabilizes everyday life, all the psychic and relational balance, inevitably causing a psychological and social change not only in the patient who is affected but also into the wide social network around him (family, friends, doctors, healthcare team). The aim of this review is t…

Physician-patient relationCommunicationMedicine (all)Burnout; Communication; Compliance; Oncologic disease; Physician-patient relations; Medicine (all)BurnoutComplianceOncologic disease
researchProduct